P. van Damme
European Journal of Neurology · 2012–2022
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from P. van Damme's perspective
Ordered by how strongly the researchers P. van Damme trusts endorse each paper. Same corpus, a different order for every researcher.
- Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis (Science)
- Prevalence and patterns of cognitive impairment in sporadic ALS (Neurology)
- TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. (Lancet Neurology)
- Mutations of optineurin in amyotrophic lateral sclerosis (Nature)
- Amyotrophic lateral sclerosis. (Current Opinion in Neurology)
- Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. (Lancet Neurology)
- Expanded GGGGCC hexanucleotide repeat in non-coding region of C9ORF72 causes chromosome 9p-linked frontotemporal dementia and amyotrophic lateral sclerosis (Neuron)
- A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD (Neuron)
- Exome sequencing reveals VCP mutations as a cause of familial ALS (Neuron)
- Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways (Science)
Their papers
- Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. (2022) — 605 citations
- Amyotrophic lateral sclerosis: a clinical review (2020) — 972 citations
- EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force (2012) — 1,090 citations